Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

629 ARTÍCULOS , VIENDO DEL 616 AL 629

Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington's Disease?

Grosso Jasutkar H, Yamamoto A.

J Huntingtons Dis. 2021;10(2):227-238. doi: 10.3233/JHD-200466.

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease

Kim J.

Int J Mol Sci. 2021 Mar 13;22(6):2929. doi: 10.3390/ijms22062929.

Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington's disease symptoms

Vega OM, Cepeda C.

Rev Neurosci. 2021 Apr 5;32(8):871-886. doi: 10.1515/revneuro-2021-0013. Print 2021 Dec 20.

Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease

Okazawa H.

Neuropathology. 2021 Apr;41(2):93-98. doi: 10.1111/neup.12738.

How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases

Bangma DF, Tucha O, Tucha L, De Deyn PP, Koerts J.

Neurosci Biobehav Rev. 2021 Aug;127:709-739. doi: 10.1016/j.neubiorev.2021.05.021. Epub 2021 May 28.

Early onset Alzheimer's disease - a case study

Łabuz-Roszak B, Torbus-Paluszczak M, Becelewski J, Becelewski M, Dobrakowski P, Pierzchała K.

Psychiatr Pol. 2021 Apr 30;55(2):323-330. doi: 10.12740/PP/OnlineFirst/114122. Epub 2021 Apr 30.

Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT)

Lunven M, Hamet Bagnou J, Youssov K, Gabadinho A, Fliss R, Montillot J, Audureau E, Bapst B, Morgado G, Reilmann R, Schubert R, Busse M, Craufurd D, Massart R, Rosser A, Bachoud-Lévi AC.

PLoS One. 2021 Aug 23;16(8):e0253064. doi: 10.1371/journal.pone.0253064. eCollection 2021.

Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease

Zhao X, Kumari D, Miller CJ, Kim GY, Hayward B, Vitalo AG, Pinto RM, Usdin K.

J Huntingtons Dis. 2021;10(1):149-163. doi: 10.3233/JHD-200423.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.

Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.

Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature

Swift IJ, Bocchetta M, Benotmane H, Woollacott IO, Shafei R, Rohrer JD.

Neurobiol Aging. 2021 Mar;99:100.e9-100.e15. doi: 10.1016/j.neurobiolaging.2020.08.014. Epub 2020 Aug 25.

Effectiveness of sorting tests for detecting cognitive decline in older adults with dementia and other common neurodegenerative disorders: A meta-analysis

Foran AM, Mathias JL, Bowden SC.

Neurosci Biobehav Rev. 2021 Jan;120:442-454. doi: 10.1016/j.neubiorev.2020.10.013. Epub 2020 Oct 20.

Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease

Du G, Dong W, Yang Q, Yu X, Ma J, Gu W, Huang Y.

Front Immunol. 2021 Feb 19;11:603594. doi: 10.3389/fimmu.2020.603594. eCollection 2020.

Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies

Schwartz JL, Jones KL, Yeo GW.

Crit Rev Biochem Mol Biol. 2021 Feb;56(1):31-53. doi: 10.1080/10409238.2020.1841726. Epub 2020 Nov 10.

Effect of nutrition on neurodegenerative diseases. A systematic review

Bianchi VE, Herrera PF, Laura R.

Nutr Neurosci. 2021 Oct;24(10):810-834. doi: 10.1080/1028415X.2019.1681088. Epub 2019 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias